Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 440 | 430 | 240 | 290 | 340 |
| TOTAL | $440 | $430 | $240 | $290 | $340 |
| Non-Current Assets | |||||
| Investments And Advances | 510 | 400 | 400 | 320 | 310 |
| Other Non-Current Assets | 9,160 | 7,720 | 4,000 | 3,040 | 2,820 |
| TOTAL | $9,670 | $8,120 | $4,400 | $3,360 | $3,130 |
| Total Assets | $10,110 | $8,550 | $4,640 | $3,650 | $3,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250 | 230 | 210 | 180 | 160 |
| Accrued Expenses | 930 | 670 | 680 | 450 | 400 |
| TOTAL | $1,180 | $900 | $5,390 | $2,160 | $560 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,060 | 5,150 | 510 | 1,170 | 750 |
| TOTAL | $8,060 | $5,150 | $510 | $1,170 | $750 |
| Total Liabilities | $9,240 | $6,050 | $5,900 | $3,330 | $1,310 |
| Shareholders' Equity | |||||
| Common Shares | 10,800 | 10,800 | 10,800 | 10,800 | 10,800 |
| TOTAL | $10,800 | $10,800 | $10,800 | $10,800 | $10,800 |
| Total Liabilities And Equity | $20,040 | $16,850 | $16,700 | $14,130 | $12,110 |